Sphera Funds Management »

Satellos Bioscience shares owned by Sphera Funds Management

Quarter-by-quarter ownership of Satellos Bioscience shares owned by Sphera Funds Management from 13F filings

Historical chart of Sphera Funds Management investment in Satellos Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Satellos Bioscience held by Sphera Funds Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Satellos Bioscience by Sphera Funds Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $2.8M 489k 5.63

More positions owned by Sphera Funds Management

Mineralys Therapeutics (MLYS)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Tower Semiconductor Shs New (TSEM)
Spdr Series Trust State Street Spd Put Option (XBI)
NOVA MEASURING Instruments L (NVMI)
Cytokinetics Com New (CYTK)
Bridgebio Pharma (BBIO)
Biogen Idec (BIIB)
Ultragenyx Pharmaceutical (RARE)
Syndax Pharmaceuticals (SNDX)
Cogent Biosciences (COGT)
Sanofi Sa Sponsored Adr (SNY)
Astrazeneca Ord (AZN)
Amicus Therapeutics (FOLD)
Cellebrite Di Ordinary Shares (CLBT)

View all positions for Sphera Funds Management

Top funds holding Satellos Bioscience

Franklin Resources
Vivo Capital
Point72 Asset Management
Woodline Partners
Sphera Funds Management
Suvretta Capital Management
Soleus Capital Management
Avidity Partners Management
Millennium Management
683 Capital Management
Empery Asset Management
ADAR1 Capital Management
Citadel Advisors
Hrt Financial
Morgan Stanley

View all funds holding Satellos Bioscience